Posted in | News | Signal Processing

US DoD AIMS Certifies MEADS Mode 5 Identification Friend or Foe Subsystem

The Medium Extended Air Defense System (MEADS) Mode 5 Identification Friend or Foe (IFF) subsystem has received full certification for operation by the United States Department of Defense International AIMS (Air Traffic Control Radar Beacon System, Identification Friend or Foe, Mark XII/Mark XIIA, Systems) Program Office. The system is designed to ensure the safety of allied aircrews engaged in combat operations.

Mode 5 IFF capability is incorporated into both MEADS radars to better protect allied pilots.

Mode 5 is the most secure IFF mode and provides positive identification of friendly platforms equipped with an IFF transponder. This helps to discriminate between friend and foe. Full certification by the DoD International AIMS Program Office is a milestone accomplishment for the MEADS program.

“Achieving full certification for this equipment, at this phase of development, MEADS has more ability to identify and protect friendly aircraft than any other air and missile defense system,” said NATO MEADS Management Agency (NAMEADSMA) General Manager Gregory Kee. “The certification confirms that MEADS’ radars provide maximum protection for allied pilots in combat environments.”

The certified IFF system is used in both MEADS 360-degree radar configurations. The Surveillance Radar is a 360-degree, active electronically steered array radar that provides extended range coverage. The Multifunction Fire Control Radar is a 360-degree X-band, solid-state, phased array radar that provides precision tracking and wideband discrimination and classification capabilities. Both radars provide threat-detection capability against highly maneuverable, low-signature threats, including short- and medium-range ballistic missiles, cruise missiles and other air-breathing threats.

“MEADS development priorities included responding to issues that arose during the conflict in Iraq, and we have taken the issue of fratricide very seriously,” said MEADS International President Dave Berganini. “That is why we have raised the bar on protection for allied aircrews. MEADS also provides complete 360-degree defense and eight times the coverage against next-generation threats.”

MEADS International, a multinational joint venture headquartered in Orlando, Florida, is the prime contractor for the MEADS system. Major subcontractors and joint venture partners are MBDA in Italy and Germany, and Lockheed Martin in the United States. Selex Sistemi Integrati of Italy provides the MEADS IFF suite.

The MEADS program management agency, NAMEADSMA, is located in Huntsville, Ala.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lockheed Martin Corporation. (2019, February 24). US DoD AIMS Certifies MEADS Mode 5 Identification Friend or Foe Subsystem. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=7937.

  • MLA

    Lockheed Martin Corporation. "US DoD AIMS Certifies MEADS Mode 5 Identification Friend or Foe Subsystem". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=7937>.

  • Chicago

    Lockheed Martin Corporation. "US DoD AIMS Certifies MEADS Mode 5 Identification Friend or Foe Subsystem". AZoSensors. https://www.azosensors.com/news.aspx?newsID=7937. (accessed November 21, 2024).

  • Harvard

    Lockheed Martin Corporation. 2019. US DoD AIMS Certifies MEADS Mode 5 Identification Friend or Foe Subsystem. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=7937.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.